Kappa-opioid antagonists as stress resilience medications for the treatment of alcohol use disorders
Crossref DOI link: https://doi.org/10.1038/s41386-018-0046-4
Published Online: 2018-03-27
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chavkin, Charles http://orcid.org/0000-0001-8048-476X
Text and Data Mining valid from 2018-03-27
Article History
Received: 10 February 2018
Revised: 27 February 2018
Accepted: 3 March 2018
First Online: 27 March 2018
Competing interests
: The author declares no competing interests.